The only thing standing between humanity and the end of HIV

A new drug called lenacapavir might entirely change the game, though.

‘Game-changing’ HIV jab to be offered in England and Wales

A long-acting injection designed to prevent HIV is set for approval in England and Wales. The cabotegravir (CAB-LA) treatment ...
Medscape

NICE Endorses UK’s First Injectable PrEP to Curb HIV

NICE has recommended cabotegravir, the UK’s first long-acting injectable HIV prevention drug, expanding access for people unable to take daily tablets.

England and Wales to get long-lasting HIV prevention jab for first time

People in England and Wales will soon have access to a long-lasting HIV prevention jab for the first time. The National ...
Newspoint on MSN

HIV AIDS: How the risk of HIV increases, understand stage by stage how dangerous its symptoms become.

If someone becomes infected with HIV and does not seek timely treatment, the infection gradually progresses through three ...
The Mail & Guardian

The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?

The once-every-six-months shot, called lenacapavir (LEN), works 100% of the time to stop young women from getting HIV through ...
pharmaphorum

ViiV's bimonthly HIV PrEP jab cleared for use by NHS

Reimbursement authority NICE has said that Apretude (cabotegravir) can now be used as an alternative to daily oral PrEP pills ...

Long-acting HIV prevention injection to be made available in England and Wales

The NHS is set to roll out a long-term HIV prevention injection in England and Wales, in a move that has been hailed as ...
STAT

In overlooked cellular connections, this researcher charted Zika’s path to the placenta

A few months into his postdoctoral research at Baylor College of Medicine in 2021, Rafael Michita made a curious observation.
AllAfrica on MSN

South Africa: The Six-Monthly Anti-HIV Jab is Coming. But Can South Africa Keep Track of Millions of Users?

In April next year , South Africa plans to start rolling out an anti-HIV jab, taken only twice a year, that could end Aids in the country within 14 to 18 years . But is our public health system ...

Immunotherapy approach offers hope for long-term HIV control without daily medication

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...

HIV rates are highest in the American South, despite effective treatments – a clash between culture and public health

(THE CONVERSATION) The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly ...